Grégory Upert

Grégory Upert

Auto-generated profile, based on publicly available information

Grégory Upert

Department of Chemistry, University of Basel, St. Johanns-Ring 19, 4056 Basel (Switzerland)

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MWMarkus Wiesner
Markus Wiesner
GUGrégory Upert
Grégory Upert
GAGaetano Angelici
Gaetano Angelici
HWHelma Wennemers
Helma Wennemers

23 December 2011 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
GUGrégory Upert
Grégory Upert
FBFrancelin Bouillère
Francelin Bouillère
HWHelma Wennemers
Helma Wennemers

28 April 2009 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KBKirsten Belser
Kirsten Belser
TSTünde Vig Slenters
Tünde Vig Slenters
CPConelious Pfumbidzai
Conelious Pfumbidzai
GUGrégory Upert
Grégory Upert
LMLaurent Mirolo
Laurent Mirolo
HWHelma Wennemers
Helma Wennemers

26 May 2023 in Science Advances
Verified
Journal Article
Open access
MSMatthias Schuster
Matthias Schuster
EBEmile Brabet
Emile Brabet
KOKathryn K. Oi
Kathryn K. Oi
NDNicolas Desjonquères
Nicolas Desjonquères
KMKerstin Moehle
Kerstin Moehle
OZOliver Zerbe
Oliver Zerbe
The rise of antimicrobial resistance poses a substantial threat to our health system, and, hence, development of drugs against novel targets is urgently needed. The natural peptide thanatin kills Gram-negative bacteria by targeting proteins of the lipopolysaccharide transport (Lpt) machinery. Using the thanatin scaffold together with phenotypic medicinal chemistry, structural data, and a target-focused approach, we developed antimicrobial peptides with drug-like properties. They exhibit potent activity against Enterobacteriaceae both in vitro and in vivo while eliciting low frequencies of resistance. We show that the peptides bind LptA of both wild-type and thanatin-resistant Escherichia coli and Klebsiella pneumoniae strains with low-nanomolar affinities. Mode of action studies revealed that the antimicrobial activity involves the specific disruption of the Lpt periplasmic protein bridge.

1 September 2008 in Oligonucleotides
Verified
Journal Article
Closed access
MMMohamed Mehiri
Mohamed Mehiri
GUGregory Upert
Gregory Upert
STSnehlata Tripathi
Snehlata Tripathi
AGAudrey Di Giorgio
Audrey Di Giorgio
RCRoger Condom
Roger Condom
NPNadia Patino
Nadia Patino
With the aim of developing a general and straightforward procedure for the intracellular delivery of naked peptide nucleic acids (PNAs), we designed an intracellularly biodegradable triphenylphosphonium (TPP) cation based transporter system. In this system, TPP is linked, via a biolabile disulfide bridge, to an activated mercaptoethoxycarbonyl moiety, allowing its direct coupling to the N-terminal extremity of a free PNA through a carbamate bond. We found that such TPP-PNA-carbamate conjugates were highly stable in a cell culture medium containing fetal calf serum. In a glutathione-containing medium mimicking the cytosol, the conjugates were rapidly degraded into an unstable intermediate, which spontaneously decomposed, releasing the free PNA. Using a fluorescence-labeled PNA–TPP conjugate, we demonstrated that conjugates were taken up by cells. Efficient cellular uptake and release of the PNA into the cytosol was further confirmed by the anti-HIV activity measured for the TPP-conjugate of a 16-mer PNA targeting the TAR region of the HIV-1 genome. This conjugate exhibited an IC50 value of 1 μM, while the free 16-mer PNA did not inhibit replication of HIV in the same cellular test.

23 December 2011 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
GUGrégory Upert
Grégory Upert
FBFrancelin Bouillère
Francelin Bouillère
HWHelma Wennemers
Helma Wennemers